drugset
drugset / Trial / NCT02762708

The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes

NCT02762708 ↗

Phase 2 Completed 12 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelBasic science

Summary

What are the benefits of undergoing Roux-en-Y gastric bypass surgery in improving type 2 diabetes outside of weight loss alone?

Timeline

Start
2016-03
Primary completion
2018-01-06
Completion
2018-01-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Avexitide Peptide — —

Indications

obesity disorder type 2 diabetes mellitus